A Donegal County Councillor has said that ‘dangerous subsidence’ on an east Donegal road is posing a serious road safety problem.Councillor Gerry Crawford said the busy regional road in Carrickmore, between Derry (via St Johnston) and Lifford, s looking for the County Council to take action.Crawford told Donegal Daily: “The road carries a very high volume of traffic throughout the year, including HGVs and cross-border traffic. “The road, up until August 10th, was used as a nightly diversion when repairs on the A5 were taking place.“It is of strategic importance and it is incredibly busy but this dangerous subsidence is not being properly marked.”A traffic cone, with a tied on hi-vis jacket, has been positioned near the area in question to warn drivers of the danger, but Crawford insists that has already been blown from its position more than once.“The cone has been blown into the culvert and lifted out already today (Weds) and it is something that needs immediate action because it has the potential to cause a serious accident,” Crawford explained. “The Donegal County Council have been informed and I am now waiting on them to take action.”Calls to repair ‘dangerous subsidence’ on road in east Donegal was last modified: August 14th, 2019 by Shaun KeenanShare this:Click to share on Facebook (Opens in new window)Click to share on Twitter (Opens in new window)Click to share on LinkedIn (Opens in new window)Click to share on Reddit (Opens in new window)Click to share on Pocket (Opens in new window)Click to share on Telegram (Opens in new window)Click to share on WhatsApp (Opens in new window)Click to share on Skype (Opens in new window)Click to print (Opens in new window)
Related Posts Editor’s note: This story is part of ReadWriteWeb’s Online Finance series, a weekly, three-month-long look at how the Internet has transformed finance. Up until April 15, which is the deadline for U.S. readers to file their taxes, we’ll be looking at how online finance has evolved, analyzing top web tools and posting video of our conversations with the people who are shaping online finance. If you are interested in sponsoring the rest of this Content Series on Personal Finance, please contact our COO Sean Ammirati.Mint: Leading the ChargeCurrently, the two most well-known online tools for personal finance management are arguably Mint and Intuit’s Quicken Online. Mint stood out from the pack early on because the company made it extremely easy to keep track of all your expenses. After giving Mint access to your bank and credit card account, the service simply downloads your financial information at regular intervals and organizes it. Mint can even track your 401(k) for you. Mint launched in September 2007 and quickly became the darling of the Web 2.0 world. Unlike most of its desktop-bound competitors, Mint managed to talk to virtually every bank and credit card issuer from day one. In October 2008, Mint came out of beta. Today, the company has more than 1.7 million registered users and sees roughly 700,000 active users every month. In October 2009, the company was signing up 30,000 new users per week. Mint’s success didn’t go unnoticed by the incumbent market leaders and Intuit acquired Mint in October 2009. In November 2009, Intuit announced that it would begin to phase out Quicken Online in favor of Mint. Microsoft suspended sales of Microsoft Money on June 30, 2009 and doesn’t plan to compete in the market anymore. Correction: In December, Microsoft actually announced a plan to enter the personal finance market again with a Mint-like tool it is developing in collaboration with Citi.Beyond MintWhile Mint gets most of the mindshare on the web these days, it’s by no means the only player in this market. Indeed, the success of Mint has given rise to a plethora of similar tools and legitimizes the efforts of companies that tried to enter this market before Mint. ClearCheckbook.com, for example, launched in May 2006. The company focuses on bringing checkbook management online. A number of other tools are competing more directly with Mint. Wesabe, for example, also focuses on giving users an overview of how they spend their money. Sadly, Wesabe makes downloading your information from your checking and credit card accounts a bit more difficult than Mint. Since acquiring Exepnsr, Strands now also offers its own personal finance tool for setting up and tracking personal budgets and staying on top of your finances. Geezeo – which was founded in 2006, and also looks a lot like Mint, has a very strong focus on budgeting.Most of these tools focus on the U.S. market, but more and more of them are also now available outside of the United States. Kublax, for example, offers a Mint-like service in the U.K.Going MobileJust like almost every other category of online tools, personal finance tools are also making the move to mobile. Mint and Wesabe, for example, offer both an iPhone app and mobile-optimized websites. Most importantly, all of these services are also able to send out alerts to your phone – either through push alerts on the iPhone or as text messages. Whenever you run the risk of exceeding your credit card limit, for example, these services will send you an alert. Of course, a number of banks have also gotten into this game and now offer their own mobile apps. The Bank of America, Chase Mobile and Wells Fargo apps are currently among the top 10 most downloaded free finance iPhone apps, for example.When it comes to paying your bills, apps like BillMinder and BillTracker make it easy to never forget when a bill is due. What’s Next?Over the last few years, the web has clearly transformed the way we use personal finance software. Over the next few months, we will have a closer look at the current generation of personal budgeting and finance tools on the web. We will also analyze the current trends around online finance software.This is the first post in our upcoming series about online finance. If you are interested in sponsoring the rest of this Content Series on Online Finance, please contact our COO Sean Ammirati. Top Reasons to Go With Managed WordPress Hosting Tags:#Features#Finance#Product Reviews#Trends#web frederic lardinois Why Tech Companies Need Simpler Terms of Servic… Not too long ago, personal finance tools like Quicken and Microsoft Money used to be bound to the desktop. Exchanging information with your banks used to be a hassle. Keeping track of credit card purchases was often a question of waiting for statements to arrive by mail and then entering data by hand. Today, free tools like Mint, moneyStrands and Wesabe make it easy to track all of this information. Thanks to this, you can now get a better overview of your personal finances than ever before. 8 Best WordPress Hosting Solutions on the Market A Web Developer’s New Best Friend is the AI Wai… RWW’s Online Finance Series:How The Web is Transforming Personal FinanceThe Evolving Online Finance Ecosystem
Turner’s cable news net CNN International has hired Owen Wyatt for a newly-created digital and affiliate sales role.Wyatt joins from YouTube channel operator Base79. At CNN International he will be tasked with growing the range of affiliates the news channel works with and developing its training and consultancy services.CNN’s new recruit will report to Greg Beitchman, CNN International’s vice president, content sales and partnerships who joined the company from Reuters late last year. He said: “With Owen on-board CNN’s partners can expect even more innovation and enterprising commercial opportunities.”Wyatt said: “As the leading global player in news, CNN also has a huge opportunity to grow our distribution with out of home partners in mutually beneficial relationships that takes CNN content to an even greater audience on new and innovative platforms.”Prior to Base79, Wyatt was head of video at newswire Reuters and a producer at Sky Sports.CNN’s international said his appointment marked another step in Rani Raad’s restructuring of the commercial business since becoming chief commercial officer in February 2013.
US pay TV providers will lose 26% of their legacy subscriber base by 2030 amid growing competition from virtual pay TV providers, according to The Diffusion Group (TDG).The research and advisory firm said it expects legacy multichannel video programming distributors (MVPDs) to experience “considerable subscriber losses” in the coming years.TDG tips legacy pay TV penetration to fall from 81% of US households in 2017 to 60% in 2030. Over the same time period it expects the penetration of virtual pay TV services – such as Sling TV, DirecTV Now and YouTube TV – to grow from roughly 4% of US households to 14%. This marks an increase of 350% but from a very small base.“TDG said early on that the future of TV was an app. Unfortunately, most incumbent MVPDs weren’t taking notes,” said Joel Espelien, TDG senior analyst.“The question is no longer if the future of TV is an app, but how quickly and economically incumbents can adapt to this truth and transition to an all-broadband app-based live multi-channel system.”Overall TDG’s report, ‘The Rise of the Virtual Pay TV Provider’, claims that the penetration of live multi-channel pay TV services will decline from 85% of US households in 2017 to 79% in 2030.It said that while this represents a loss of only 7%, it illustrates the “ongoing secular decline of a once healthy market space”.TDG predicts that by 2030, roughly 30 million US households will live without an MVPD service of any kind.
Get 1 Year of Green Entrepreneur for $19.99 Cannabis Journalist | Tech Evangelist Covering High Growth Trends 8 min read Next Article Image credit: Kevork Djansezian | Getty Images Add to Queue Guest Writer Andre Bourque Green Entrepreneur provides how-to guides, ideas and expert insights for entrepreneurs looking to start and grow a cannabis business. People growing their own marijuana is a significant concern to Big Pharma. As state legalization of cannabis-derivatives spreads, the drug companies contemplating the potential of medical marijuana see a threat from both homegrown and professionally harvested medical-grade marijuana.Pharma offers quality control and deep testing but experience shows that research and development adds to customer cost. Even the 21st Century Cures Act won’t speed up the famously slow pace of FDA drug approvals. Given the facts and the perception, you have to wonder if Big Pharma is for or against legalizing marijuana.Related: Science and FDA Say Cannabis Is Medicine but DEA Insists It Isn’tHere’s the problem.A lot of money always attracts a lot interest. Big Pharma wants the revenues that marijuana promises but concede market forces threaten their interests. Big Pharma can’t getting its biggest slice of the pie with individuals and licensed producers harvesting cannabis, not to mention the the black market that continues to thrive.Ben Cohen, writing for US News, insists it’s all about money. He writes, “For years, large corporations and well-heeled lobbyists have blocked the legalization of marijuana for medical use or recreational use in order to protect their own profits.”There’s no reason to expect this to stop.On the other hand, cannabis advocates have a personal and emotional investment in promoting the legalization, or at least decriminalization, of marijuana. Sometimes that makes them anti-institutional and they skew the role of Big Pharma. Finding an objective point of view is difficult.You might consider the hypocrisy at the February 2014 meeting of the Community Anti-Drug Coalition of America (CADCA). While speaker after speaker preached against the legalization of marijuana, leading financial sponsors of the program included Purdue Pharma, the manufacturer of Oxycontin.As reported in The Nation, both CADCA and the Partnership for Drug-Free Kids (formerly the Partnership for a Drug-Free America) accept financial support from the producers of the same opioid medications that have led to tens of thousands of deaths. The same two groups, among others, have opposed U.S. Congressional efforts to label prescription opioids for “severe pain,” but they have supported continuing Medicare reimbursement for the addictive pills.Moreover, pharmaceutical companies take shelter in the DEA’s listing of marijuana as a Schedule 1 drug, the same category as heroin. As long as the DEA effectively prohibits marijuana medical research, Big Pharma can take the moral high road. The Schedule 1 designation severely limits needed research into the medical efficacy of cannabis-derivatives.”Big pharma is lobbying against legalization, on the purported grounds of safety, but in reality, they are just buying time to create their own synthetic cannabis medicines,” said Alan Hirsch, CEO of Diagnostic Lab Corporation, a cannabis safety and science company. “Several biotech companies have started creating cannabinoid chemistry from rice or yeast, but eventually, these medicines will be manufactured by Big Pharma in Schedule 1 facilities.” Big Pharma Is Developing Cannabis Painkillers – Here’s What They Can Do To Become Part of the Mainstream Market. https://t.co/WGj1yWE2rv pic.twitter.com/s0w3fmzsPe— HIGH TIMES (@HIGH_TIMES_Mag) July 19, 2017 The problem that started with the Trump campaign.Many of the same voters who elected President Donald J. Trump voted to liberalize marijuana enforcement. And, like everything else with the arrival of the Trump administration, things remain in a state of confusion pending official updated stance.In a Town Hall (03/20/2016) meeting, then-candidate Trump said, “I think that as far as drug legalization we talk about marijuana and in terms of medical I think I am basically for that. I’ve heard some wonderful things in terms of medical. I’m watching Colorado very carefully to see what’s happening out there.”Related: Getting Healthy, Not High: Using Cannabis to Fight CancerOn The O’Reilly Factor (02/12/2016), when Fox News’ Bill O’Reilly called medical marijuana a “ruse,” candidate Trump said, “But I know people that have serious problems and they did that they really — it really does help them.”Later, candidate Trump told the Washington Post (10/29/2016), “In terms of marijuana and legalization, I think that should be a state issue, state-by-state … Marijuana is such a big thing. I think medical should happen — right? Don’t we agree? I think so. And then I really believe we should leave it up to the states.”Decades ago he also told the Miami Herald (04/14/1990) “We’re losing badly the War on Drugs. You have to legalize drugs to win that war. You have to take the profit away from these drug czars.”Confusion about the Trump Administration and cannabis.President Donald J. Trump has sent several confusing signals to the pharmaceutical industry and the cannabis advocates. NewsMaxFinance (03/03/3017) quoted President-elect Trump as saying, “pharmaceutical companies are ‘getting away with murder’ in what they charge the government for medicines.” President Trump repeated that charge at a press conference reported by the Washington Post (01/11/2017) when he also said, “Pharma has a lot of lobbies, a lot of lobbyists and a lot of power.”Fox Business (02/01/2017) interviewed Eli Lilly’s CEO David A. Ricks following Trump’s White House meeting with pharmaceutical industry leaders. “When asked if he gave the president any commitment to reducing drug prices or to investing in U.S. operations or jobs, Ricks responded, ‘No, Lilly didn’t do that. But, what we did say is that with the right policy environment, in particular, the corporate tax rate which today is an inhibitor for us to invest in manufacturing here in the United States, along with other pro-business policies could allow us to expand operations in the U.S’.”Related: Will the ‘Entrepreneur’ President Embrace the Cannabis Economy?And, Emma Court of MarketWatch (03/01/2017) reported following Trump’s first State of the Union Address, “The Tuesday evening mention of drug prices underscores ‘our view that Trump is committed to some action to permit federal government involvement in pricing under Medicare Part D, his position for a year,’ Evercore ISI policy analyst Terry Haines said. ‘We continue to think that comes during ACA reform legislation when Trump can insist something be included as a condition of him signing the bill into law.’”So perhaps President Trump is jawboning the pharmaceutical industry to make a deal? Trump wants some concession he can take to his populist constituency in trade for lower corporate taxes. On the surface, this has nothing to do with marijuana. In fact, his position on marijuana may be something he can trade.Related: Marijuana Advocates Wait for Trump’s Stance on Legalized CannabisIt’s all about the money.Is Big Pharma for or against legalizing marijuana? Nothing shows that they favor accessibility to marijuana, and everything points to their opposition. However, investors in Big Pharmacy see the light. They remain in the market and are buying up. They see that there’s no moral high road here but there is money for Big Pharma in cannabis.“No pharmacy company is interested in making cheaper medicine,” Brian Chaplin, founder of Medicine Box told me in a written interview. “The existing Pharma industry is more about patenting and manufacturing medicine that is a treatment plan – not a curative plan.”Chaplin argues that Big Pharma wants customers to need their products, preferably for the rest of their lives, while creating “customers” but not healing specific ailments.“This is different from a ‘whole plant’ medicine approach — where we see patients responding to the synergistic effects of multiple compounds (cannabanoids and terpenes) in the plant that are usually lacking in a pharmacy — chemically prepared product,” he continued. Interestingly, Big Pharma playing in the fields of cannabis might, in fact, help declassify the plant. Christopher Teague of HERB writes, “Big Pharma will prove that cannabis is medicine a hundred times over, in every way, and the DEA will have to reclassify the plant itself.”According to Matt Gray, CEO and founder of HERB, “Big Pharma has already dipped its toe into cannabis treatment, with the DEA approving synthetic cannabis for pharma company, Insys.”That same company, however, also donated money to prevent cannabis legalization from occurring in Arizona. “This just proves the point that Big Pharma cares more about their bottom line than the actual treatment of patients,” he continued. “So if they find it financially beneficial, they will get involved in the industry, even if it isn’t necessarily for the right reasons.”In the end, it’s all about striking a winning balance. Trump needs a victory over high drug prices, especially as they affect Medicare Part D. Big Pharma is in a position to demand concessions. Accessibility to cannabis R&D might just be one of them. Pharmaceutical companies are intrigued by the immense and growing medical marijuana market but cannot figure a way to corner it. Cannabis August 8, 2017 –shares Opinions expressed by Entrepreneur contributors are their own. Is Big Pharma for or Against Legalizing Medical Marijuana? Maybe Both. Subscribe Now
Social Media Reporter Next Article Guest Writer Michael Kan Free Webinar | July 31: Secrets to Running a Successful Family Business 2 min read Image credit: JaysonPhotography / Shutterstock.com Learn how to successfully navigate family business dynamics and build businesses that excel. Russian efforts to influence American society over social media may have reached more than half of the country’s voting population, according to new findings that’ll be presented to Congress today.Facebook, for instance, has found that 126 million users in the country may have been exposed to 80,000 divisive political posts written by a Kremlin-back Russian company, according to The New York Times.Twitter uncovered over 36,000 accounts possibly linked with Russia that generated 1.4 million automated election-related tweets, according to a source familiar with its upcoming testimony. Those tweets received 288 million impressions.Google, on the other hand, found 1,108 videos on YouTube probably associated with a suspected Russian campaign to spread propaganda. The videos attracted 309,000 views in the U.S.More details will be presented during today’s congressional hearing on Russian interference in last year’s election. Representatives from all three U.S. tech companies are set to testify.Facebook will reportedly disclose that a Russian company called the Internet Research Agency controlled 470 accounts to publish the 80,000 posts. Those posts were served directly to 29 million users, and then liked, shared or followed by others, magnifying their spread.Russia’s Internet Research Agency, which is notorious for being an Internet troll farm, also spent $100,000 to display 3,000 ads on the platform with divisive political and social messages, Facebook claimed last month.Twitter also tracked over 2,700 users accounts to the Russian company, up from the 201 accounts it initially reported last month. All the accounts have been suspended. In addition, Twitter identified over 36,000 accounts found generating automated election-related content that possessed “at least one characteristic” associated with Russian user accounts.Although the accounts produced 1.4 million tweets, that only represented 0.74 percent of overall election-related tweets during the Sept. 1 to Nov. 15 time period, according to Twitter’s upcoming testimony.Despite Facebook’s and Twitter’s attempts to crack down on the abuse, U.S. lawmakers remain concerned that foreign governments will try to spread propaganda over their platforms in future elections. That may put Silicon Valley and Washington at odds over attempts to regulate social media.However, both Facebook and Twitter are taking steps to add more transparency to their online political ad business, including who buys what. Last week, Twitter banned two Russian media groups from advertising on the platform over concerns they were spreading Kremlin-back propaganda. Facebook, Google and Twitter are set to testify before a congressional subcommittee on Russia’s attempt to use social media to influence last year’s election. Facebook Says 126 Million Users May Have Been Exposed to Russian Posts –shares October 31, 2017 Add to Queue This story originally appeared on PCMag Register Now »
Add to Queue –shares Be inclusive, be respectful, and beware of the after party. Holidays December 11, 2017 Guest Writer Image credit: Ulrik Tofte | Getty Images Jonathan Segal Partner in Employment Practice Group of Duane Morris 8 Ways to Increase Holiday Cheers and Minimize January Jeers Next Article Apply Now » Opinions expressed by Entrepreneur contributors are their own. The holiday season can be the most wonderful time of the year, but it also poses legal and employee relations challenges to employers of all sizes. Most of these challenges can be mitigated with some thoughtful planning. So, here’s a checklist of some of the more salient issues to consider to minimize the risk that your December celebrations will result in January claims.1. Don’t eliminate Christmas.Don’t eliminate Christmas from the holiday season, says this Jewish guy. It’s a beautiful holiday that should be celebrated. And, a Christmas tree is just fine, too! Remember, it’s about inclusion, not exclusion. So, speaking of inclusion — what about those who don’t celebrate Christmas?Related: 6 Strategic Ways to Prepare Your Small Business for the Festive Season2. Include other holidays.Recognize other holidays, such as Hanukkah and Kwanza, in your decorations and announcements. For example, consider a menorah and Kwanza basket along with the Christmas tree. 3. What holiday did you forget?You don’t know what you don’t know. Profound, no? So, ask. Ask employees if there is a holiday that they would like to see included in the celebration (and that includes decorations). Reminder: the Buddhist holiday of Bodhi day falls on January 5 this year. 4. What should you call your party?“Holiday party” or “Celebration of the Season” are inclusive terms. Make the party itself inclusive too by having decorations and the music reflect diverse holidays. But which decorations and songs? Those that are more religious are more appropriate for religious celebrations (or for religious employers). Fact: Springsteen’s “Santa Claus is Coming to Town” is just fine!Related: 4 Ways to Prepare Your Marketing for the Upcoming Holiday Season5. Should you serve alcohol?Never serve it to minors. Make clear adults who get it for them will be subject to immediate discharge. As for adults, take steps to minimize abuse, such as limiting drinks, providing lots of food or even making employees pay for alcohol and then donating the money, with a match, to charity.Even with restrictions, assume some people may abuse the alcohol you serve. Consider having cab vouchers ready for them without management knowing who the users are. This increases the likelihood that those who need vouchers will use them.6. What about harassment?This is perennial problem at holiday parties. But you can bet this year employees who are subject to improper conduct appropriately will speak up. #MeToo. Remind your employees that your anti-harassment policy applies to the party. But that’s not enough. Make sure to remind managers of their responsibilities. If you are in management and you see or hear unacceptable comments or conduct, you must intervene. To see and ignore is to condone.7. What about the “after party?”To be blunt, no good comes from after parties. Unless, you consider claims arising out of the after party good. Make clear you are not sponsoring any after party, and do not allow employer money to be used for it. And, never attend if you are in management. Attending is about as safe as walking on railroad tracks.Related: Don’t Commit These 7 Party Fouls Inspired by ‘Office Christmas Party’8. What about greetings?It’s best to be general with your holiday greetings unless you know otherwise. The default should be “Happy Holidays.” But if you know someone is Christian, by all means wish that person a Merry Christmas. I do, and I appreciate it when people wish me a “Happy Hanukkah” because they know I am Jewish. I am less thrilled if they are making assumptions. When addressing groups, be as inclusive as you can be, as I shall try to do now: If you celebrate Christmas, Hanukkah or Kwanzaa, I wish you a peaceful and meaningful holiday that corresponds with your faith. If you observe another holiday now, I apologize for not referencing it by name, but I give you my good wishes just the same, as I do for those who recognize no holidays or who celebrate at another time of year. May peace be with all! And, please, be good to each other. 4 min read The only list that measures privately-held company performance across multiple dimensions—not just revenue. 2019 Entrepreneur 360 List
Add to Queue March 19, 2018 Apple Is Reportedly Trying to Make its Own Displays Next Article –shares 2 min read Matthew Humphries Image credit: via PC Mag Senior Editor Apple’s laptops, smartphones, tablets and watches rely on hundreds of parts, most of which Apple sources from other companies around the world. But the more of those parts Apple can make itself, the more profit it can generate as well as making its supply chain more reliable. Apple already started making its own chips, now it’s attempting to make displays.As Bloomberg reports, Apple is thought to be designing and producing its own displays in a secret manufacturing facility near California. More specifically, the focus is on producing MicroLED screens like those recently produced by Samsung to form the 146-inch modular TV launching in August.In Apple’s case, perfecting MicroLED screen production would remove the need to rely on companies including Samsung, Japan Display, Sharp, and LG Display. We could see Apple displays used in the Apple Watch ($329.00 at Best Buy), iPhone, iPad and maybe even MacBooks ($1,249.00 at Amazon) in the future, but there’s one big problem: MicroLED is extremely difficult to manufacture.Apple’s focus on MicroLED is due to the benefits offered, notably they create thinner, brighter and less power-hungry displays without the downsides of OLED (limited life span, brightness). However, because each pixel has its own light in a MicroLED array, it throws up some manufacturing challenges. Those challenges apparently almost made Apple shut down the project last year, but it didn’t, and now working displays are being produced.It’s unlikely we’ll see these Apple displays any time soon, if at all. The cost of mass producing OLED and eventually MicroLED will continue to fall and other manufacturers already focused on display production will benefit first. Apple would need to invest heavily in facilities before it could get serious about making displays. So, for the foreseeable future, expect Apple to continue signing display contracts with its partners. Free Webinar | July 31: Secrets to Running a Successful Family Business This story originally appeared on PCMag Apple If successful, Apple will no longer have to rely on another company for its screens. Learn how to successfully navigate family business dynamics and build businesses that excel. Register Now »
Lindsay Friedman Are You in the Top 50 Percent of Earners in Your City? — Start Up Your Day Roundup Next Article Staff writer. Frequently covers franchise news and food trends. Register Now » 2 min read Free Webinar | July 31: Secrets to Running a Successful Family Business Opinions expressed by Entrepreneur contributors are their own. Add to Queue March 10, 2016 Learn how to successfully navigate family business dynamics and build businesses that excel. Start Up Your Day Image credit: Shutterstock Everyone can give you the headlines. We help you learn from the day’s shifts, both big and small. McDonald’s opens in Borat’s home country. The Big Mac comes to Kazakhstan, according to the New York Post. The fast food franchise opened its first location in the country on Tuesday.The tipping point. Looking at the amount of money it takes to make it into the top 1 or 10 percent of earners can be downright dispiriting. But cracking the top 50 percent? That’s not as discouraging! In New York City, for example, if you make $52,000 a year you’re earning more than 50 percent of residents, according to Business Insider.Just like in the movies. Goodyear unveiled spherical tires, similar to the ones seen in the Will Smith movie I, Robot, at the Geneva International Motor Show. While the tires are still a concept, they’re pretty cool to look at. Venture Beat has more.Watch a Google smart car hit a bus. The very slow, very anti-climactic video is finally out and ready for you to see.Lost and out of network on the road? Try out this new GPS application, which stores maps on your smartphone for offline use. It now covers the entire globe, save for a couple of volcanic islands and Antarctica. –shares